Direct Oral Anticoagulants are rapid and short acting agents which have relatively low bleeding risks and overall safety. Direct oral anticoagulants are alternative choice for blood clot treatment in selected patients.
This report contains market size and forecasts of Direct Oral Anticoagulant in global, including the following market information:
Global Direct Oral Anticoagulant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Direct Oral Anticoagulant Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Direct Oral Anticoagulant companies in 2021 (%)
The global Direct Oral Anticoagulant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Apixaban Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Direct Oral Anticoagulant include Bristol-Meyers Squibb Co, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc., Bayer AG, Teva Pharmaceutical Industries Ltd, Pab Organics Private Limited and Daiichi Sankyo Company, Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Direct Oral Anticoagulant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Direct Oral Anticoagulant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Direct Oral Anticoagulant Market Segment Percentages, by Type, 2021 (%)
Apixaban
Dabigatran
Rivaroxaban
Edoxaban
Global Direct Oral Anticoagulant Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Direct Oral Anticoagulant Market Segment Percentages, by Application, 2021 (%)
Hospitals Pharmacies
Drug Stores
Online Pharmacies
Global Direct Oral Anticoagulant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Direct Oral Anticoagulant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Direct Oral Anticoagulant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Direct Oral Anticoagulant revenues share in global market, 2021 (%)
Key companies Direct Oral Anticoagulant sales in global market, 2017-2022 (Estimated), (MT)
Key companies Direct Oral Anticoagulant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Meyers Squibb Co
Pfizer Inc.
Boehringer Ingelheim Pharmaceuticals, Inc
Janssen Pharmaceuticals, Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd
Pab Organics Private Limited
Daiichi Sankyo Company, Limited